SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-18-042472
Filing Date
2018-08-07
Accepted
2018-08-07 16:51:57
Documents
2
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS II, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G tv500349_sc13g.htm SC 13G 74221
2 EXHIBIT 1 tv500349_ex-1.htm EX-99.1 6026
  Complete submission text file 0001144204-18-042472.txt   81985
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89113 | Film No.: 18998793
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners II, LLC (Filed by) CIK: 0001647491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G